Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer:

Inken Flörkemeier,Tamara N. Steinhauer,Nina Hedemann,Magnus Ölander,Per Artursson,Bernd Clement,Dirk Bauerschlag

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer:

2021

Inken Flörkemeier
Tamara N. Steinhauer
Nina Hedemann
Magnus Ölander
Per Artursson
Bernd Clement
Dirk Bauerschlag

Background:Ovarian cancer (OvCa) constitutes a rare and highly aggressive malignancy and is one of the most lethal of all gynaecologic neoplasms. Due to chemotherapy resistance and treatment limita...

Keywords:

chemotherapy resistance
Cancer research
Ovarian cancer
Apoptosis
Medicine
Malignancy
Drug development
Topoisomerase inhibitor
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations